send comments on the haematology clinical guidelines Please complete this form and submit your comments or amendments Your Details: Your Name: Your Email:   Guideline Chapter/Section: Chapter/Section: Choose One 1. INTRODUCTION 2. IMAGING FOR HAEMATOLOGICAL MALIGNANCIES 3. CLASSICAL HODGKIN LYMPHOMA 4. LYMPHOCYTE PREDOMINANT NODULAR HODGKIN LYMPHOMA (LPNHL) 5. DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) 5.1. PRIMARY AND SECONDARY CEREBRAL LYMPHOMA 5.2. CNS PROPHYLAXIS FOR PRESENTING PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA 5.3. HIV ASSOCIATED LYMPHOMA 6. BURKITT LYMPHOMA 7. FOLLICULAR LYMPHOMA 8. CHRONIC LYMPHOCYTIC LEUKAEMIA 9. MANTLE CELL LYMPHOMA 10. SYSTEMIC MARGINAL ZONE LYMPHOMA 11. EXTRANODAL MARGINAL ZONE LYMPHOMA (MALT-TYPE LYMPHOMA) 11.1. GASTRIC MARGINAL ZONE LYMPHOMA 11.2. NON-GASTRIC EXTRANODAL MZL 12. HAIRY-CELL LEUKAEMIA 13. PERIPHERAL T-CELL LYMPHOMA 13.1. ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA (AITL) 13.2. ANAPLASTIC LARGE CELL LYMPHOMA, ALK +VE / -VE (ALCL) 13.3. PERIPHERAL T-CELL LYMPHOMA NOS (PREVIOUSLY 'UNSPECIFIED') 13.4. ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA 13.5. EXTRANODAL NK/T-CELL LYMPHOMA, NASAL-TYPE 13.6. ALK +VE ANAPLASTIC LARGE CELL LYMPHOMAS - T(2;5) AND / OR ALK+VE 13.7. PERIPHERAL T-CELL LYMPHOMA, NOS AND ALK NEGATIVE ALCL 13.8. ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA 13.9. ENTEROPATHY-ASSOCIATED T CELL LYMPHOMA 13.1. EXTRANODAL NK/T-CELL LYMPHOMA, NASAL-TYPE 13.11. T-PROLYMPHOCYTIC LEUKAEMIA 14. CUTANEOUS LYMPHOMA 14.1. PRIMARY CUTANEOUS T CELL LYMPHOMA 15. MULTIPLE MYELOMA AND RELATED DISORDERS 15.1. MULTIPLE MYELOMA 15.2. MONOCLONAL GAMMOPATHY OF UNCERTAIN SIGNFICANCE (MGUS) 15.3. PLASMACYTOMA OF BONE 15.4. EXTRAMEDULLARY PLASMACYTOMA 15.5. MONOCLONAL DEPOSITION DISEASE (INCLUDING AMYLOIDOSIS) 15.6. INVESTIGATION AND MANAGEMENT 15.7. SOLITARY PLASMACYTOMA OF BONE AND EXTRAMEDULLARY PLASMACYTOMA 15.8. AMYLOIDOSIS 16. ACUTE MYELOID LEUKAEMIA 17. PRECURSOR CELL LYMPHOBLASTIC LEUKAEMIA IN ADULTS 17.1. PRECURSOR B-CELL LYMPHOBLASTIC LEUKAEMIA 17.2. PRECURSOR T-LYMPHOBLASTIC LEUKAEMIA 17.3. IMMUNOLOGIC CLASSIFICATION OF ALL (LUDWIG, ET AL 1994) 17.4. RISK FACTORS: ANY OF THE FOLLOWING 18. MYELODYSPLASTIC SYNDROMES 18.1. MYELODYSPLASTIC / MYELOPROLIFERATIVE NEOPLASMS 19. CHRONIC MYELOID LEUKAEMIA 20. CHRONIC MYELOPROLIFERATIVE DISORDERS 21. PALLIATIVE CARE 22. REPORTING PATHOLOGICAL SPECIMENS FROM HAEMATO-ONCOLOGY PATIENTS 22.1. INTRODUCTION 22.2. NETWORK POLICY 22.3. DESIGNATED PATHOLOGISTS 22.4. REPORTING STANDARDS 22.5. EXPECTED REPORTING TIMES 22.6. INVESTIGATION PROTOCOLS 22.7. PROCEDURE FOR REFERRAL OF SPECIMEN 22.8. SPECIMEN TYPES HANDLED BY HMDS 22.9. COLLECTION AND TRANSPORT OF TISSUE SPECIMENS 22.1. URGENT AND OUT OF HOURS SPECIMENS 22.11. TRANSMISSION OF REPORTS 22.12. REFERENCES 23. FACILITIES NECESSARY FOR PROVISION OF INTENSIVE CHEMOTHERAPY (NICE 2003) 23.1. FACILITIES 23.2. STAFFING 23.3. CLINICAL SUPPORT 24. CARE PATHWAYS FOR TEENAGERS AND YOUNG ADULTS WITH A HAEMATOLOGICAL MALIGNANCY 25. GUIDELINES FOR CONVENTIONAL CYTOGENETIC ANALYSIS IN ADULT PATIENTS 25.1. B-CELL LYMPHOPROLIFERATIVE DISORDERS INCLUDING MYELOMA 25.2. CHRONIC MYELOPROLIFERATIVE DISORDERS 25.3. ACUTE LYMPHOBLASTIC LEUKAEMIA 25.4. ACUTE MYELOID LEUKAEMIA 25.5. MYELODYSPLASTIC SYNDROMES 25.6. CHRONIC MYELOID LEUKAEMIA 26. AUDIT & DATA COLLECTION PROTOCOL 27. THE INTERNATIONAL PROGNOSTIC INDEX (IPI) 28. FLIP INDEX FOR FOLLICULAR LYMPHOMA (FLIPI) 29. ANN ARBOR STAGING CLASSIFICATION FOR NHL 30. BINET DISEASE STAGE FOR CLL 31. INTERNATIONAL HODGKIN LYMPHOMA PROGNOSTIC SCORE: 32. ECOG PERFORMANCE STATUS 33. KARNOFSKY PERFORMANCE STATUS SCALE 34. WEBSITES 35. REFERENCES Page Number: Comments:

	Haematology